著者氏名 論文タイトル名

101 研究成果の刊行に関する一覧表：

刊行書籍

著者氏名 論文タイトル名

書籍全 体の編 集者名

書 籍 名 出版社 名

出版 地

出版 年

ペー ジ

岡本高宏 甲状腺腫瘍 . 福 井 次 矢、高木 誠、小 室 一 成 編

今日の治療指針

2021 医学書

院

東京

2021 pp 8 1 0 - 8 11

岡本高宏 甲状腺良性腫瘍 矢 崎 義 雄編

新臨床内科学 医学書 院

東京

2020 pp 8 9 4 - 8 95

岡本高宏 甲状腺悪性腫瘍 矢 崎 義 雄編

新臨床内科学 医学書 院

東京

2020 pp 8 9 5 - 8 97 弦間昭彦

弦 間 昭

彦

薬剤性肺障害分 析ファイル ビ ックデータを紐 解くエキスパー トオピニオン

南江堂

川井 章 全国骨・軟部腫瘍登録 川井 章 肉腫-基礎・臨床 の最新知見-

日 本 臨 牀社

東京 2020 35-42

河野浩二 他

日本バイ オセラピ イ学会 日本癌治 療学会

よ く わ か る が ん 免 疫 療 法 ガ イ ド ブック

金 原 出 版

東京 2020 1-120

Kobayashi H, Sugih ara K.

Lateral Pelvic Lym

ph Node Dissection Hohenb

erger W Springer Surger y Atlas Series Lower Gastroin testinal Tract Surgery Vol 2, Open procedure s

Spring

er Swit

zerla nd

2021 299-3 16

袴田健一 消化器外科医の倫理 とプロフェッショナ リズム

日本消化 器外科学 会専門医 制度委員 会

消化器外科専門 医の心得

一般社 団法人 日本消 化器外 科学会

東京 2020 p4-6

102

長谷川 潔, 國土 典宏

【消化器悪性腫瘍診 療におけるガイドラ インの功罪】肝癌診療 におけるガイドライ ンの功罪(解説/特集)

小立健太 外科82巻6号 (株)南 江堂

日本 2020 629-6 34

雑誌

発表者氏名 論文タイトル名 発表誌名 巻号 ページ 出版年

Aogi K., Takeu chi H., Saeki T., Aiba K., Ta mura K., Iino K., Imamura K,C., Okita K., Kagami Y., Ta naka R., Nakag awa K., Fujii H., Wada M., Akechi T., Iiha ra H., Ohtani S., Okuyama A., Ozawa K., Kim Y., Sasaki H., Shima Y., Takeda M., Na gasaki E., Nish idate T., Higas hi T,, Hirata K

Optimizing antiemetic treatment for chemoth erapy-induced nausea and vomiting in Japa n: Update summary of the 2015 Japan Socie ty of Clinical Oncolog y Clinical Practice Gu idelines for Antiemesis

Int J Clin Onco l.

https://doi.org/1 0,1007/s10147- 020-01818-3 Nov 2020

2020

103 Ohge H, Mayu

mi T, Haji S, Kitagawa Y, K obayashi M, Ko bayasi M, Mizu guchi T, Mohri Y, Sakamoto F, Shimizu J, Su zuki K, Uchino M, Yamashita C, Yoshida M, Hirata k, Sumi yama Y, Kusac hi S, & The Co mmitteee for G astroenterologic al Surgical Site Infection Guid elines, the Japa n Society for S urgical Infectio n

The Japan Society for Surgical Infection: gui delines for the preven tion, detection, and m anagement of gastroen terological surgical sit e infection, 2018

Surgery Today https://doi.org/1 0,1007/s00595- 020-02182-6

2020

amaguchi H, Ki mura Y, Imam ura M, Nagaya ma M, Ito T, K yuno D, Kono T, Kimura A, Akizuki E, Nis hidate T, Okita K, Nobuoka T, Mizuguchi T, Hirata K, Take masa I

Effect of Rikkunshito, a traditional Japanese herbal medicine, on delayed gastric emptyi ng and oral dietary in take after pancreatico duodenectomy: a prosp ective randomized, sin gle-center, open-labele d study

Clin Experiment

Gastroenterol 13 577-587

Hayashi N、Kum amaru H,Isozumi U, Aogi K, Asa ga S,Iijima K, K adoya T, Kojima Y, Kubo M, Miya shita M, Miyata H, Nagahashi M, Niikura N, Ogo E, Tamura K, Ta nakura K, Yamamoto Y, Yo shida M, Imoto S, Jinno H.

Annual report of the Ja panese Breast Cancer R egistry for 2017.

Breast Cancer 27（5） 803-809 2020

104

a N, Kumamaru H, Takeuchi Y, Okamura T, Kin oshita T, Aogi K, Anan K, Iijima K, Ishida T, Iwamoto T, K awai M, Koji ma Y, Sakatani T, Sagara Y, H ayashi N, Masuo ka H, Yoshida M, Miyata H, T suda H, Imoto S, Jinno H

Breast cancer survival a mong Japanese individu als and US residents o f Japanese and othe r origins: a comparative registry-based study.

Breast Cancer Re s Treat

doi:10.1007/s10549 -020-05869-y2.

2020

Ariake K, Mizum a M, Motoi F, M aeda S, Morikaw a T, Ishida M, O htsuka H, Aoki S, Miura T, Taka date T, Nakagaw a K, Kamei T, U nno M.

Preceding Systemic Che motherapy for Patients with Pancreatic Ductal Adenocarcinoma with Po sitive Peritoneal Cytolog y Provides Survival Ben efit Compared with Up- Front Surgery.

Ann Surg Oncol doi: 10.1245/s104

34-021-09718-0. 2021

Aoki S, Mizuma M, Hayashi H, Y oshimachi S, Hat a T, Miura T, Ta kadate T, Maeda S, Ariake K, Ka waguchi K, Masu da K, Ishida M, Ohtsuka H, Nak agawa K, Morika wa T, Motoi F, Unno M.

Prognostic impact of intr aoperative peritoneal cyt ology after neoadjuvant t herapy for potentially re sectable pancreatic cance r.

Pancreatology 20 1711-1717 2020

105

kawa T, Ishida M, Aoki S, Hata T, Iseki M, Miur a T, Ariake K, Maeda S, Kawag uchi K, Masuda K, Ohtsuka H, Mizuma M, Haya shi H, Nakagawa K, Motoi F, Ka mei T, Naitoh T, Unno M.

Staging laparoscopy is m andatory for the treatme nt of pancreatic cancer t o avoid missing radiologi cally negative metastase s.

Surg Today doi: 10.1007/s005

95-020-02121-4. 2020

Mizuma M, Yam amoto H, Miyata H, Gotoh M, Un no M, Shimosega wa T, Toh Y, Ka keji Y, Seto Y.

Impact of a board certifi cation system and imple mentation of clinical pra ctice guidelines for pancr eatic cancer on mortality of pancreaticoduodenect omy.

Surg Today 50 1297-1307 2020

Kawai M, Yamau e H, Jang JY, U esaka K, Unno M, Nakamura M, Fujii T, Satoi S, Choi SH, Sho M, Fukumoto T, Kim SC, Hong T H, Izumo W, Yoo n DS, Amano R, Park SJ, Choi S B, Yu HC, Kim JS, Ahn YJ, Kim H, Ashida R, Hi rono S, Heo JS, Song KB, Park J S, Yamamoto M, Shimokawa T, Ki m SW.

Propensity score-matched analysis of internal ste nt vs external stent for pancreatojejunostomy du ring pancreaticoduodenec tomy: Japanese-Korean c ooperative project.

Pancreatology 20 984-991 2020

106

moto Naoya Niwa Masayuki Hagiw ara Takeo Kosaka Nobuyuki Tanaka Toshikazu Taked a Shinya Morita Ryuichi Mizuno Toshiaki Shinoji ma Satoshi Hara Hiroshi Asanuma Mototsugu Oya

Type of patients in who m biochemical recurrenc e after radical prostatect omy can be observed wit hout salvage therapy.

World Journal of

Urology 38(7) 1749-1756 2020

Yoshinori Yanai Kazuhiro Matsu moto

Takeo Kosaka Toshikazu Taked a Nobuyuki Tanaka Shinya Morita Ryuichi Mizuno Toshiaki Shinoji ma Hiroshi Asanuma Mototsugu Oya

External validation of th e "optimal PSA follow-up schedule after radical p rostatectomy" in a new c ohort.

International Jour nal of Clinical On cology

25(7) 1393-1397 2020

Rei Kamitani Kazuhiro Matsu moto

Takeo Kosaka Toshikazu Taked a Akinori Hashiguc hi

Nobuyuki Tanaka Shinya Morita Ryuichi Mizuno Toshiaki Shinoji ma Hiroshi Asanuma Mototsugu Oya

Evaluation of Gleason G rade Group 5 in a Conte mporary Prostate Cancer Grading System and Li terature Review.

Clinical Genitouri

nary Cancer 19(1) 69-75.e5 2021

107

Eiji Kikuchi Masashi Matsush ima Koichiro Ogihara Takeo Kosaka Ryuichi Mizuno Tomoki Tanaka Naoyuki Shigema tsu

Mototsugu Oya

Relationship between ra diation doses and erectil e function deterioration i n patients with localized prostate cancer treated with permanent prostate brachytherapy.

International Jour

nal of Urology 27(12) 1087-1093 2020

Hiroji Uemura Hisashi Matsushi ma Kazuki Kobayash i

Hiroya Mizusawa Hiroaki Nishimat su

Karim Fizazi Matthew Smith Neal Shore Teuvo Tammela Ken-Ichi Tabata Nobuaki Matsuba ra Masahiro Iinuma Hirotsugu Uemur a Mototsugu Oya Tetsuo Momma Mutsushi Kawaki ta Satoshi Fukasaw a

Tadahiro Kobaya shi Iris Kuss

Marie-Aude Le B erre

Amir Snapir Toni Sarapohja Kazuhiro Suzuki

Efficacy and safety of da rolutamide in Japanese patients with nonmetast atic castration-resistant prostate cancer: a sub-gr oup analysis of the phas e III ARAMIS trial.

International Jour nal of Clinical On cology

26(3) 578-590 2021

Okamoto T, Egur o Y, Yoshida Y, Horiuchi K.

Radioactive iodine treat ment of papillary thyroid carcinoma in Japan

Gland Surgery 9 1698-1707 2020

108

moto T. Prognosis and prognostic factors in patients with intermediate-risk papilla ry thyroid carcinoma def ined by the Japanese Cli nical Practice Guidelines for Thyroid Tumours.

Otorhinolaryngol Head and Neck S urg

5 1-6 2020

Kakeji Y, Yama moto H, Ueno H, Eguchi S, Endo I, Sasaki A, Taki guchi S, Takeuch i H, Hashimoto M, Horiguchi A, Masaki T, Marub ashi S, Yoshida K, Miyata H, Ko nno H, Gotoh M, Kitagawa Y, Mo ri M, Seto Y

Development of gastroen terological surgery over t he last decade in Japan:

analysis of the National Clinical Database

Surg Today 51巻2号 187-193 2021

掛地 吉弘、長谷川 寛、金治 新悟、

北川 雄光

消化器外科領域におけるN ational Clinical Database の活用

泌尿器外科 34巻1号 47-53 2021

Katai H, Ishikaw a T, Akazawa K, Fukagawa T, Iso be Y, Miyashiro I, Oda I, Tsujita ni S, Ono H, Ta nabe S, Nunobe S, Suzuki S, Kak eji Y

Optimal extent of lymph node dissection for rem nant advanced gastric ca rcinoma after distal gast rectomy: a retrospective analysis of more than 30 00 patients from the nat ionwide registry of the J apanese Gastric Cancer Association.

Gastric Cancer 23巻6号 1091-1101 2020

掛地 吉弘、長谷川 寛、金治 新悟

【 外 科 臨 床 に 役 立 つ 統 計 学】National Clinical Dat abaseから何が引き出せる か

外科 82巻8号 830-835 2020

109

Kaneko Y, Tsutsumi M, Kanemaru M, Matsui M,

Arakawa Y, Katoh N, Inoue M, Asai J

Novel ex vivo disease model for extramammary Paget's disease using the cancer tissue-originated spheroid method

J Dermatol Sci 99 185-192 2020

Fujii K, Hamada T, Shimauchi T, Asai J, Fujisawa Y, Ihn H, Katoh N

Cutaneous lymphoma in Japan, 2012-2017: A nationwide study

J Dermatol Sci 97 187-193 2020

賀本敏行、安井孝 周、武中篤、大家基 嗣

泌尿器科でのNCDについ

て 泌尿器外科 34 16−20 2021

Demetri GD, Ant onescu CR, Bjerk ehagen B, Kawai A, et al.

Diagnosis and managem ent of tropomyosin recep tor kinase (TRK) fusion sarcomas: expert recomm endations from the Worl d Sarcoma Network.

Annals of Oncolog y: official journal of the European Society for Medica l Oncology.

11 1506-17 2020

Endo M, Takaha shi S, Araki N, Kawai A, et al.

Time lapse analysis of t umor response in patient s with soft tissue sarcom a treated with trabectedi n: A pooled analysis of t wo phase II clinical trial s.

Cancer Medicine. 11 3656-67 2020

Kawai A, Higash i T, Shibata T, Y oshida A, et al.

Rare cancers in Japan:

definition, clinical featur es and future perspectiv es.

Japanese Journal of Clinical Oncolo gy.

50（9） 970-5 2020

Tap WD, Wagner AJ, Kawai A, et al.

Effect of Doxorubicin Plu s Olaratumab vs Doxoru bicin Plus Placebo on Su rvival in Patients With Advanced Soft Tissue Sa rcomas: The ANNOUNC E Randomized Clinical T rial.

JAMA 323(13) 1266-76 2020

110

Y, Kawai A, et a l.

Expanding the clinicopat hologic and molecular sp ectrum of BCOR-associat ed sarcomas in adults.

Histopathology. 76(4) 509-20 2020

Matsumoto H, S hiraishi K, Azum a H, Inoue K, U emura H, Eto M, Ohyama C, Oga wa O, Kikuchi E, Kitamura H, Sh inohara N, Taka hashi S, Tsuzuki T, Nakagawa M, Narumi Y, Nishi yama H, Habuchi T, Hinotsu S, F ujii Y, Fujimoto K, Fujimoto H, Mizowaki T, Mat suyama H.

Clinical practice guidelin es for bladder cancer 20 19 edition by the Japane se Urological Association:

revision working positio n paper.

Int J Urol 27 362-368 2020

Matsumoto H, S hiraishi K, Azum a H, Inoue K, U emura H, Eto M, Ohyama C, Oga wa O, Kikuchi E, Kitamura H, Sh inohara N, Taka hashi S, Tsuzuki T, Nakagawa M, Narumi Y, Nishi yama H, Habuchi T, Hinotsu S, F ujii Y, Fujimoto K, Fujimoto H, Mizowaki T, Mat suyama H.

Clinical practice guidelin es for bladder cancer 20 19 update by the Japane se Urological Association:

Summary of the revisio n.

Int J Urol 27 702-709 2020

坂本信一,稲元輝生,

菊地栄次. [National Clinical Datab aseの現状] 各疾患の意義 前立腺癌.

泌尿器外科 34 27-31 2021

畠山真吾, 小林恭, 松本洋明, 菊地栄 次,武中篤, 賀本敏 行.

[National Clinical Datab aseの現状] 各疾患の意義 膀胱癌.

泌尿器外科 34 32-38 2021

111

類に応じた治療】胚細胞腫 瘍

小児外科 52(6) 631-634 2020

木下義晶 【小児泌尿器科オープンサ ージャリー-見て学ぶプロ フェッショナルの技】小児 泌尿器科プロフェッショナ ルレベルの手術 腎芽腫 小児腎腫瘍のアップデート

臨床泌尿器科 74(4) 484-489 2020

木下義晶 傍精巣横紋筋肉腫 後腹膜 リンパ節郭清の是非

小児外科 52(12) 1266-1269 2020

木下義晶 難治性小児固形悪性腫瘍に 対する新規治療

新潟医学会雑誌 134(1) 1-5 2020

Hisakane K, Seik e M, Sugano T, Matsuda K, Kun ugi S, Nakamichi S, Matsumoto M, Miyanaga A, Noro R, Noro R, Minegishi Y, Kub ota K, Gemma A.

PD-L1 expression status predicting survival in pu lmonary pleomorphic car cinoma.

Anticancer Res

Noro R, Kobayas hi K, Usuki J, Y omota M, Nishits uji M, Shimokaw a T, Ando M, Hi no M, Hagiwara K, Miyanaga A, Seike M, Kubota K, Gemma A.

Bevacizumab plus chemo therapy in nonsquamous non-small cell lung canc er patients with maligna nt pleural effusion uncon trolled by tube drainage or pleurodesis: A phase II study North East Jap an Study group trial NE J013B

Thorac Cancer.

112

no S, Sakamoto H, Yoshida H, A mino Y, Uematsu S, Yoshizawa T, Hasegawa T, Ari yasu R, Uchibori K, Yanagitani N, Horai T, Seike M, Gemma A, Ni shio M.

Addition of ramucirumab enhances docetaxel effic acy in patients who had received anti-PD-1/PD-L1 treatment.

Lung Cancer.

Kasai T, Mori K, Kishi K, Kabura gi T, Hosomi Y, Imai H, Yamada Y, Yomota M, M origuchi S, Seike M, Minato K, Ge mma A.

A phase I and extension study of S-1 and carbopl atin for previously untre ated patients aged 75 ye ars or more with advanc ed non-small cell lung c ancer.TCOG 1101.

Int J Clin Oncol

Tozuka T, Kitazo no S, Sakamoto H, Yoshida H, A mino Y, Uematsu S, Yoshizawa T, Hasegawa T, Uc hibori K, Yanagit ani N, Horiike A, Horai T, Seike M, Gemma A, Ni shio M.

Dissociated responses at initial computed tomogra phy evaluation is a good prognostic factor in non -small cell lung cancer p atients treated with anti -programmed cell death- 1/ligand 1 inhibitors.

BMC Cancer

Kono K, Nakajim a S, Mimura K.

Current status of im mune checkpoint inhibito rs for gastric cancer.

Gastric Cancer 2020 May 28. On line ahead of pri nt

2020

Masayuki Watan abe, Yuji Tachim ori, Tsuneo Oya ma, Yasushi Toh, Hisahiro Matsub ara, Masaki Uen o, Koji Kono, et al.

Comprehensive registry of esophageal cancer in Japan, 2013

Esophagus 2020 https://doi.or g/10.1007/s10388- 020-00785-y

2020

113

g, Jiafu Ji, Sang Uk Han, Masano ri Terashima, Gu oxin Li, Hyung Ho Kim, Simon Law, Asim Shabb ir, Kyo Young So ng, Koji Kono, et al

Extensive peritoneal lav age with saline after c urative gastrectomy for gastric cancer (EXPEL):

a multicentre randomise d controlled trial,

Lancet Gastroente

rol Hepatol. 2020 Nov 27:S24 68-1253(20)30315- 0. doi: 10.1016/S2 468-1253(20)3031 5-0. Online a head of print.

2020

Burasakarn P, H iguchi R, Kodera Y（著者19名中19番 目）, et al.

Limited resection vs. pa ncreaticoduodenectomy f or primary duodenal ade nocarcinoma: a systemat ic review and meta-anal ysis.

Int J Clin Oncol 26(3) 450-460 2021 Mar

Sassa N, Yokoya ma Y, Kodera Y

（ 著 者9名 中8番 目）, et al.

Clinical characteristics a nd surgical outcomes of retroperitoneal tumors: a comprehensive data coll ection from multiple dep artments.

Int J Clin Oncol 25(5) 929-936 2020 May

Ishii K, Yokoyam a Y, Kodera Y

（ 著 者9名 中6番 目）, et al.

Characteristics of primar y and repeated recurren t retroperitonal liposarco ma: outcomes after aggr essive surgeries at a sin gle institution.

Jpn J Clin Oncol 50(12) 1412-1418 2020 Dec

114

nda G, Beppu T, Kotake K, Yama moto M, Takahas hi K, Endo I, Ha segawa K, Itabas hi M, Hashiguchi Y, Kotera Y, Ko bayashi S, Yama guchi T, Tabuchi K, Kobayashi H, Yamaguchi K, M orita S, Miyazaki M, Sugihara K.

Comprehensive data of 3,525 patients newly dia gnosed with colorectal li ver metastasis between 2013 and 2014: 2nd repo rt of a nationwide surve y in Japan. 2013 and 20 14: 2nd report of a natio nwide survey in Japan.

J Hepatobiliary P

ancreat Sci 27(8) 555-562 2020

Kataoka K, Bepp u N, Shiozawa M, Ikeda M, To mita N, Kobayas hi H, Sugihara K, Ceelen W

Colorectal cancer treated by resection and extend ed lymphadenectomy: pa tterns of spread in left- and right-sided tumours

Br J Surg 107(8) 1070-1078 2020

Kobayashi H, Ya mamoto H, Miyat a H, Gotoh M, K otake K, Sugihar a K,Toh Y, Kakej i Y, Seto Y

Impact of adherence to b oard-certified surgeon sy stems and

clinical practice guideline s on colon cancer surgic al outcomes in Japan: A questionnaire survey of t he National Clinical Dat abase

Ann Gastroenterol Surg.

4(3) 283-293 2020

115

a K, Endo I, Sak amoto K, Honda G, Beppu T, Kot ake K, Yamamot o M, Takahashi K, Hasegawa K, Itabashi M, Hash iguchi Y, Kotera Y, Kobayashi S, Yamaguchi T, Ta buchi K, Kobayas hi H, Yamaguchi K, Morita S, Nat sume S, Miyazak i M, Sugihara K

Long-term outcome of liv er resection for colorectal metastases in the prese nce of extrahepatic disea se: A multi-institutional Japanese study

J Hepatobiliary Pancreat Sci

27(11) 810-818 2020

Shinto E, Ike H, Hida JI, Kobayas hi H, Hashiguchi Y, Hase K, Kish i Y, Ueno H, Su gihara K.

Proposal of a modified s ubclassification system fo r stage III colorectal can cer: A multi‐institution al retrospective analysis

Ann Gastroenterol Surg.

4(6) 667-675 2020

Kawate T, Yoshi da A, Sugae S, A saga S, Kaise H, Saji S, Yamauchi C, Miyoshi Y, Y amauchi H, Ishik awa T

Recommendations for the management of breast c ancer patients during th e COVID-19 pandemic fr om the Japan Breast Ca ncer Society.

Breast Cancer 28(2) 247-253 2021

Sawaki M, Yama da A, Kumamaru H, Miyata H, N akayama K, Shi mizu C, Miyashit a M, Honma N, Taira N, Saji S

Clinicopathological chara cteristics, practical treat ments, prognosis, and cli nical issues of older brea st cancer patients in Jap an

Breast Cancer 28(1) 1-8 2021

116

Masuda N, Tsud a H, Akiyama F, Kurosumi M, Sh imomura A, Sato N, Takao S, Ohs umi S, Tokuda Y, Inaji H, Wata nabe T, Ohashi Y.

Relationships between p athological factors and lo ng-term outcomes in pati ents enrolled in two pro spective randomized cont rolled trials comparing t he efficacy of oral tegafu r-uracil with CMF (N-SA S-BC01 trial and CUBC trial)

Breast Cancer Res

Treat. 186(1) 135-147 2021

Park YH, Senkus -Konefka E, Im SA, Pentherouda kis G, Saji S, Gu pta S, Iwata H, Mastura MY, De nt R, Lu YS, Yin Y, Smruti BK, Toyama T, Malwi nder S, Lee SC, Tseng LM, Kim JH, Kim TY, Su h KJ, Cardoso F, Yoshino T, Doui llard JY.

Pan-Asian adapted ESM O Clinical Practice Guid elines for the manageme nt of patients with early breast cancer: a KSMO- ESMO initiative endorse d by CSCO, ISMPO, JS MO, MOS, SSO and TO S.

Ann Oncol. 31(4) 451-469 2020

Shibata A, Saji S, Kamiya K, Ya sumura S

Trend in Cancer inciden ce and mortality in Fuk ushima between 2008 an d 2015.

J Epidemiol. Sep 19. doi:

10.2188/jea.J E20200202.

2020

Katanoda K, Hor i M, Saito E, Shi bata A, Ito Y, Mi nami T, Ikeda S, Suzuki T, Mats uda T.

Updated trends in cance r in Japan: incidence in 1985-2015 and mortality in 1958-2018 - a sign of decrease in cancer incide nce.

J Epidemiol. Feb 6. doi: 10.21 88/jea.JE2020041 6

Online ahead of print 2021

Shibata A, Saji S, Kamiya K, Ya sumura S.

Trend in Cancer inciden ce and mortality in Fuk ushima between 2008 an d 2015.

J Epidemiol. 2020 Sep 19. doi:

10.2188/jea.JE20 200202

Online ahead of print 2020

Usui Y, Ito H, K oyanagi Y, Shiba ta A, Matsuda T, Katanoda K, Ma eda Y, Matsuo K.

Changing trend in morta lity rate of multiple mye loma after introduction o f novel agents: A popula tion-based study.

Int J Cancer. 147(11) 3102-3109 2020

117

における全国がん登録情報 の利用の現状とこれから

臨床評価 48(2) 375-82 2020

Ogiya R, Jinno H.

et al.

Breast cancer survival among Japanese individuals and US residents of Japanese and other origins: a

comparative registry- based study.

Breast cancer research and treatment

184(2) 585 – 596 2020

Hayashi N, Jinno H.

et al.

Annual report of the Japanese Breast Cancer Registry for 2017.

Breast cancer. 27(5) 803-809 2020

Kubo M, Jinno H.

et al.

Annual report of the Ja panese Breast Cancer So ciety registry for 2016.

Breast cancer. 27(4) 511-518 2020

Ishii M, Hamabe A, Okita K, Ni shidate T, Okuya K, Usui A, Akizuki E, Satoy oshi T, Takemas a I.

Efficacy of indocyanine green fluorescence angiography in prevent ing anastomotic leakage after laparoscopic colore ctal cancer surgery.

Int J Colorectal D

is. 35(2) 269-275 2020

Takahashi H, Ha mabe A, Hata T, Nishizawa Y, Nis himura A, Itoh M, Takemasa I.

Prospective multicenter study of reduced port su rgery combined with tra nsvaginal specimen extra ction for colorectal cance r resection.

Surg Today 20 doi: 10.1007/

s00595-019-0 1946-y.

2020

Satoyoshi T, Okit a K, Ishii M, H amabe A, Usui A, Akizuki E, Okuya K, Nishid ate T, Yamano H, Nakase H, Ta kemasa I.

Timing of indocyanine green injection prior to laparoscopic colorectal surgery for tumor localization: a pros pective case series.

Surg Endosc. 35(2) 763-769. 2021

118

K, Suzuki H, Suzuki K, Tsuboi M, Mitsudomi T,

Takao M, Murakawa T, Ito H, Yoshimura K, Okada M, Chida M.

Salvage surgery for non- small cell lung cancer af ter tyrosine kinase inhib itor treatment.

Lung Cancer 153 108-116 2021

Suda K, Mitsudo mi T, Shintani Y, Okami J, Ito H, Ohtsuka T, T oyooka S, Mori T, Watanabe SI, Asamura H, Chid a M, Date H, En do S, Nagayasu T, Nakanishi R, Miyaoka E, Oku mura M, Yoshino I; Japanese Join t Committee of L ung Cancer Regis try.

Clinical Impacts of EGF R Mutation Status: Anal ysis of 5780 Surgically R esected Lung Cancer Ca ses.

Ann Thorac Surg 111 269-276 2021

Ikeda N, Endo S, Fukuchi E, Nak ajima J, Yokoi K, Chida M, Date H, Iwasaki A, o komise H, Sato M, Okumura M, Yamamoto H, Mi yata H, Kondo T.

Current status of surger y for clinical stage IA lu ng cancer in Japan: anal ysis of the national clini cal database.

Surg Today. 50 1644-1651 2020

Fukumoto K, Mo ri, S, Shintani Y, Okami J, Ito H, Ohtsuka T, Toy ooka S, Mori T, Watanabe S, Asa mura H, Chida M, Date H, Endo S, Nagayasu T, Nakanishi R, Mi yaoka E, Okumu ra M, Yoshino I

Impact of the preoperati ve body mass index on t he postoperative outcome s in patients with compl etely resected non-small cell lung cancer: A retro spective analysis of 16,5 03 cases in a Japanese Lung Cancer Registry St udy.

Lung Cancer 149 120-129 2020

119

A, Shiotani M, O nozuka D, Yama ki C, Shimizu N, Morita S, Takay ama T.

Employing multiple-attri bute utility technology to evaluate publicity activi ties for cancer informati on and counseling progr ams in Japan.

Journal of Cancer

Policy in press 2021

Watanabe M, Ta chimori Y, Oyam a T, Toh Y, Mat subara H, Ueno M, Kono K, Uno T, Ishihara R, M uro K, Numasaki H, Tanaka K, O zawa S, Muraka mi K, Usune S, Takahashi A, Mi yata H, Registrat ion Committee fo r Esophageal Ca ncer of the Japa n Esophageal Soc iety.

Comprehensive registry of esophageal cancer in Japan, 2013.

Esophagus 18 1-24 2021

Committee for Sc ientific Affairs, T he Japanese Asso ciation for Thora cic Surgery; Shi mizu H, Okada M, Toh Y, Doki Y, Endo S, Fuku da H , Hirata Y, Iwata H, Kobaya shi J, Kumamaru H, Miyata H, M otomura N, Nat sugoe S, Ozawa S, Saiki Y, Saito A, Saji H, Sato Y, Taketani T, T anemoto K, Tang oku A, Tatsuishi W, Tsukihara H, Watanabe M, Ya mamoto H, Mina toya K, Yokoi K, Okita Y, Tsuchid a M, Sawa Y.

Thoracic and cardiovascu lar surgeries in Japan d uring 2018 : Annual rep ort by the Japanese Ass ociation for Thoracic Sur gery.

General Thoracic and Cardiovascula r Surgery

69 179-212 2021

120

H, Tachimori Y, Uno T, Jingu K., Nemoto K, M atsubara H.

Current status of radiot herapy for patients with thoracic esophagealcance r in Japan, based on the Comprehensive Registry of EsophagealCancer in Japan from 2009 to 201 1 by the Japan Esophag eal Society.

Esophagus 17 25-32 2020

Committee for Sc ientific Affairs, T he Japanese Asso ciation for Thora cic Surgery, Shi mizu H, Okada M, Tangoku A, D oki Y, Endo S, F ukuda H, Hirata Y, Iwata H, Kob ayashi J, Kuma maru H, Miyata H, Motomura N, Natsugoe S, Oza wa S, Saiki Y, S aito A, Saji H, S ato Y, Taketani T, Tanemoto K, Tatsuishi W, Toh Y, Tsukihara H, Watanabe M, Ya mamoto H, Yokoi K, Okita Y.

Thoracic and cardiovascu lar surgeries in Japan d uring 2017 : Annual rep ort by the Japanese Ass ociation for Thoracic Sur gery.

Gen Thorac Cardi

ovasc Surg 68 414-449 2020

Nagase S, Ohta T, Takahashi F, Yaegashi N; Boar d members of th e 2020 Committe e on Gynecologic Oncology of the Japan Society of Obstetrics and G ynecology. Ann ual report of the Committee on Gy necologic Oncolog y, the Japan Soci ety of Obstetrics and Gynecology

Annual patient report fo r 2017 and annual treat ment report for 2012.

J Obstet Gynaecol

Res. Feb 25 doi: 10.1111/j og.14724. 2021

121

agase S, Takahas hi F, Ino K, Hac hisuga T, Mikam i M, Enomoto T, Katabuchi H, Ao ki D.

A retrospective study for investigating the relatio nship between old and n ew staging systems with prognosis in ovarian can cer using gynecologic can cer registry of Japan Soc iety of Obstetrics and G ynecology (JSOG): dispar ity between serous carci noma and clear cell carc inoma.

J Gynecol Oncol. 31(4) e45 2020

Machida H, Mats uo K, Matsuzaki S, Yamagami W, Ebina Y, Kobaya shi Y, Tabata T, Kaneuchi M, Nag ase S, Enomoto T, Mikami M.

Proposal of a Two-Tier S ystem in Grouping Aden ocarcinoma of the Uterin e Cervix

Cancers (Basel) 12(5) 1251 2020

Shigeta S, Shida M, Nagase S, Ike da M, Takahashi F, Shibata T, Ya magami W, Kata buchi H, Yaegash i N, Aoki D, Mik ami M.

Epidemiological guideline influence on the therap eutic trend and patient outcome of uterine cervic al cancer in Japan: Japa n society of gynecologic oncology guideline evalu ation committee project.

Gynecol Oncol. 159 248-255 2020

Saotome K, Yam agami W, Machid a H, Ebina Y, K obayashi Y, Taba ta T, Kaneuchi M, Nagase S, En omoto T, Aoki D, Mikami M.

Impact of lymphadenecto my on the treatment of endometrial cancer using data from the JSOG ca ncer registry.

Obstet Gynecol Sc

i. 64 80-89 2021

成田善孝 脳腫瘍の分類と疫学 日本臨床 79巻増刊号1 187-193 2021

122

e M, Mishima K, et al.,

Phase I/II study of tirab rutinib, a second-generat ion Bruton's tyrosine kin ase inhibitor, in relapsed /refractory primary centr al nervous system lymph oma.

Neuro Oncol 23(1) 22-33 2021

Iihara K, Tomina ga T, Narita Y, e t al.,

The Japan Neurosurgical Database: Overview and Results of the First-yea r Survey.

Neurol Med Chir

(Tokyo). 60(4) 165-90 2020

Takami H, Perry A, Narita Y, et a l.,

Comparison on epidemiol ogy, tumor location, hist ology, and prognosis of i ntracranial germ cell tu mors between Mayo Clin ic and Japanese consorti um cohorts.

J Neurosurg. Jan 31 1-11 2020

Tanaka S, Sato I, Narita Y, et a l.

Validation study of the Japanese version of MD Anderson Symptom Inve ntory for Brain Tumor module.

Jpn J Clin Oncol. online online 2020

Kawai A, Higash i T, Shibata T, Y oshida A, Katoh Y, Fujiwara Y, N ishida T.

Rare cancers in Japan:

definition, clinical featur es and future perspectiv es.

Jpn J Clin Oncol. 50(9) 970-975 2020

Nishida T, Doi

T. A New Approach to Refr actory GIST with Divers e Acquired Mutations.

Lancet Oncol. 21(7) 864-865 2020

123

akawa Y, Toyam a H, Takeda Y, Maeda A, Kuma moto Y, Nakamu ra Y, Hashida K, Honda G, Fu kuzawa K, Toyo da E, Tanabe M, Gotohda N, Ma tsumoto I, Ryu T, Uyama I, Koji ma T, Unno M, Ichikawa D, Ino ue Y, Matsukaw a H, Sudo T, Ta kaori K, Yamaue H, Eguchi S, T ahara M, Shinze ki M, Eguchi H, Kurata M, Mori moto M, Hayashi H, Marubashi S, Inomata M, K imura K, Amaya K, Sho M, Yosh ida R, Murata A, Yoshitomi H, Hakamada K, Y asunaga M, Abe N, Hioki M, Tsu chiya M, Misawa T, Seyama Y, Noshiro H, Saka moto E, Hasega wa K, Kawabata Y, Uchida Y, K ameyama S, Ko S, Takao T, Kita hara K, Nakahir a S, Baba H, W atanabe M, Yam amoto M, Naka mura M.

A multicenter prospectiv e registration study on l aparoscopic pancreatecto my in Japan: report on the assessment of 1,429 patients

J Hepatobiliary P ancreat Sci .

27(2) 47-55 2020

Ishido K, Hakam ada K, Kimura N, Miura T, Wak iya T.

Essential updates 2018/2 019: Current topics in th e surgical treatment of p ancreatic ductal adenoca rcinoma

Ann Gastroenterol

Surg 5(1) 7-23 2020

124

jimoto Y, Yagi S, Kobayashi T, A kamatsu N, Shi mamura T, Imur a S, Ogiso S, Mi zuno S, Takatsuk i M, Fukuhara T, Kanto T, Eguc hi S, Yanaga K, Ogura Y, Fukum oto T, Shimada M, Hasegawa K, Ohdan H, Uemot o S, Soejima Y, I kegami T, Yoshiz umi T, Taketomi A, Maehara Y.

De novo hepatocellular c arcinoma developing in t he living donor liver gra fts: A Japanese multicen ter experience.

Hepatol Res 50(12) 1365-1374 2020

Iida H, Tani M, Aihara T, Hasega wa K, Eguchi H, Tanabe M, Yama moto M, Yamaue H.

New metastasectomy crit eria for peritoneal metas tasis of hepatocellular ca rcinoma: A study of the Japanese Society of Hep ato-Biliary-Pancreatic Su rgery.

J Hepatobiliary P

ancreat Sci 27(10) 673-681 2020

Fukami Y, Kaneo ka Y, Maeda A, Kumada T, Tana ka J, Akita T, K ubo S, Izumi N, Kadoya M, Saka moto M, Nakashi ma O, Matsuyam a Y, Kokudo T, Hasegawa K, Ya mashita T, Kashi wabara K, Takay ama T, Kokudo N, Kudo M

Liver Cancer Study Gro up of Japan. Liver Resec tion for Multiple Hepato cellular Carcinomas: A J apanese Nationwide Sur vey.

Ann Surg 272(1) 145-154 2020

125

K, Hasegawa K, Ariizumi S, Kob ayashi T, Kamiy ama T, Kudo A, Yamaue H, Koku do N, Yamamoto M

Impact of systematic seg mentectomy for small he patocellular carcinoma.

J Hepatobiliary P

ancreat Sci 27(6) 331-341 2020

Kim DS, Kim B W, Hatano E, H wang S, Hasega wa K, Kudo A, A riizumi S, Kaibor i M, Fukumoto T, Baba H, Kim SH, Kubo S, Kim JM, Ahn KS, C hoi SB, Jeong C Y, Shima Y, Nag ano H, Yamasaki O, Yu HC, Han DH, Seo HI, Par k IY, Yang KS, Yamamoto M, W ang HJ.

Surgical Outcomes of He patocellular Carcinoma With Bile Duct Tumor T hrombus: A Korea-Japan Multicenter Study.

Ann Surg 271(5) 913-921 2020

Shin

Ishihara,Akihiko Horiguchi, Itaru Endo

Toshifumi Wakaki, Satoshi Hirano, Hiroki Yamaue

Prognostic impact of the number of metastatic ly mph nodes in distal bile duct cancer: An analysis of Japanese registration cases by the study group for biliary surgery of th e Japanese Society of H epato-Biliary-Panvreatic Surgery.

Journal of Hepato -Biliary-Pancreatic Sciences

27 396－401 2020

126

YukioAsano,Norih ikoKawabe,Hideto shiNagata, Yuka Kondo, ShinpeiFu ruta, Masahiro Shimura, Chihiro Hayashi, Takayu ki,

Ochi, Kenshiro Kamio, Toki Kawai, Hironobu Yasuoka,Takahik

Hi hi hi

Resection of pancreatic a nd splenic metastases fr om alveolar soft part sar coma: a case repert

Surgical Case Rep

orts 6(139) Online journ

al のためペー ジ数なし（全8 ページ）

2020

Masui T, Ito T, Komoto I, Uemot o S; JNETS Proj ect Study Group.

Recent epidemiology of p atients with gastro-enter o-pancreatic neuroendocri ne neoplasms (GEP-NE N) in Japan: a populatio n-based study.

BMC Cancer. 20(1): 1104. 2020

増井俊彦 肝 胆 膵 領 域 腫 瘍 に お け Borderline resectable /Marginally resectable と は7. 膵神経内分泌腫瘍

日本外科学会雑誌 第122巻第2 号 172-177 2021

増井俊彦 上本伸 二

特集・消化器悪性腫瘍診療 におけるガイドラインの功 罪 8 NET診療におけるガ イドラインの功罪

臨床雑誌“外科” 第82巻第6 号 650-655 2020

Shinagawa T, Ha ta K, Ikeuchi H, Fukushima K, F utami K, Sugita A, Uchino M, Wa tanabe K, Higash i D, Kimura H, Araki T, Mizushi ma T, Itabashi M, Ueda T, Koga nei K, Oba K, Is hihara S, Suzuki Y

Rate of Reoperation Decr eased Significantly After Year 2002 in Patients w ith Crohn's Disease.

Clin Gastroenterol

Hepatol 18(4) 898-907 2020

127

a K, Fukunaga Y, Takeda T, Fuj ii M, Yamaguchi T, Kagawa Y, Mi zushima T, Ohno Y, Yao T, Doki Y, Sugihara K

Analysis of Clinicopathol ogical Characteristics of Appendiceal Tumors in J apan: A Multicenter Coll aborative Retrospective Clinical Study- A Japane se Nationwide Survey.

Dis Colon Rectum 63(10) 1403-1410 2020

Yamaguchi T, M urata K, Shiota T, Takeyama H, Noura S, Sakamo to K, Suto T, Ta kii Y, Nagasaki T, Takeda T, Fuj ii M, Kagawa Y, Mizushima T, Oh no Y, Yao T, Kis himoto M, Sugih ara K

Study Group of Appendi ceal Neoplasms in the J SCCR. Clinicopathologica l Characteristics of Low- Grade Appendiceal Muci nous Neoplasm.

Dig Surg Online ahead of

print 2021

Sekine I, Shintan i Y, Shukuya T, Takayama K, Ino ue A, Okamoto I, Kiura K, Takah ashi K, Dosaka-A kita H, Takiguch i Y, Miyaoka E, Okumura M, Yos hino I.

A Japanese lung cancer registry study on demographics and treatment modalities in medically treated patients.

Cancer Science 111 1685-1691 2020

Igawa S, Naoki K, Shintani Y, S ekine I, Shukuya T, Takayama K, Inoue A, Okamo to I, Kiura K, Ta kahashi K, Yama moto N, Takiguc hi Y, Miyaoka M, Yoshino I.

Survival and prognostic factors in elderly patients receiving second-line chemotherapy for relapsed small-cell lung cancer: Results from the Japanese Joint.

Committee of Lung Cancer Registry

Lung Cancer 146 160-164 2020

128

jima K, Fukunag a K, Shintani Y, Skine I, Shukuya T, Takayama K, Inoue A, Okamo toI, Kiura K, Ta kahashi K, Yama moto N, Takiguc hi Y, Miyaoka E, Okumura M, Yo shino I.

Key prognostic factors fo r EGFR-mutated non-ad enocarcinoma lung canc er patients in the Japa nese JointCommittee of Lung Cancer database.

Lung Cancer 146 236-243 2020

Fukumoto K, Mo ri S, Shintani Y, Okami J, Ito H, Ohtsuka T, Toyo oka S, Mori T, Watanabe S, Asa mura H, Chida M, Date H, Endo S, Nagayasu T, Nakanishi R, Mi yaoka E, Okumu ra M, Yoshino I.

Impact of the preoperat ive body mass index on the postoperative outcom es in patient with compl etely resected non-small cell lung cancer: A retro spective analysis of 16,5 03 cases in a Japanese Lung Cancer Registry St udy

Lung Cancer 149 120-129 2020

Suda K, Mitsudo mi T, Shintani Y, Okami J, Ito H, Ohtsuka T, T oyooka S, Mori T, Watanabe S, Asamura H, Chid a M, Date H, En do S, Nagayasu T, Nakanishi R, Miyaoka E, Oku mura M, Yoshino I.

Clinical impacts of EG FR mutation status:

Analysis of 5780 surgic ally resected lung cancer cases.

Ann Thorac Sur

g 111 269-276 2021